Meeting Coverage
ACAAI
American College of Allergy, Asthma & Immunology
Monoclonal antibodies, BTK inhibitor alleviate symptoms when antihistamines fall short
Latest ACAAI Meetings
More kids had responses, decreased symptom severity, versus those who received placebo
Pharmacokinetics in healthy cohort looks promising
No safety concerns reported and swelling attacks declined
PTAH, already approved for those ages 4-17, also attenuated the sensitivity in younger children
Albuterol-budesonide also reduced time with severe exacerbations
Implementation barriers included parental fears, pediatrician time crunch
Are moisturizers to blame for increased chances for childhood food allergies?
OUtMATCH assesses omalizumab as single-agent and add-on therapy
Accelerated interdermal skin testing not tied AEs in small study
Mostly no, says military doctor
Two new products show midstage promise in hereditary angioedema
It's the unnecessary, crippling worry about the possibility of it
Reactions diminish over time in open-label study
Parents say their docs didn't make a point of recommending it